Related Experiment Video
Updated: Jan 6, 2026
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diffusion basis spectrum imaging for identifying pathologies in MS subtypes
Afsaneh Shirani1,2, Peng Sun3, Kathryn Trinkaus4
1The John L. Trotter Multiple Sclerosis Center and Neuroimmunology Section, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri.
Abstract:
Diffusion basis spectrum imaging (DBSI) combines discrete anisotropic diffusion tensors and the spectrum of isotropic diffusion tensors to model the underlying multiple sclerosis (MS) pathologies. We used clinical MS subtypes as a surrogate of underlying pathologies to assess DBSI as a biomarker of pathology in 55 individuals with MS. Restricted isotropic fraction (reflecting cellularity) and fiber fraction (representing apparent axonal density) were the most important DBSI metrics to classify MS using brain white matter lesions. These DBSI metrics outperformed lesion volume. When analyzing the normal-appearing corpus callosum, the most significant DBSI metrics were fiber fraction, radial diffusivity (reflecting myelination), and nonrestricted isotropic fraction (representing edema). This study provides preliminary evidence supporting the ability of DBSI as a potential noninvasive biomarker of MS neuropathology.
Insights
Diffusion basis spectrum imaging (DBSI) shows promise as a biomarker for multiple sclerosis (MS) neuropathology. Specific DBSI metrics effectively classify MS subtypes and outperform lesion volume in detecting underlying pathologies.
Area of Science:
- Neuroimaging
- Biomarkers
- Multiple Sclerosis Research
Background:
- Multiple Sclerosis (MS) involves complex neuropathologies affecting white matter.
- Current biomarkers may not fully capture the spectrum of MS pathology.
- Diffusion Basis Spectrum Imaging (DBSI) offers advanced modeling of tissue microstructure.
Purpose of the Study:
- To evaluate Diffusion Basis Spectrum Imaging (DBSI) as a noninvasive biomarker for multiple sclerosis (MS) neuropathology.
- To correlate DBSI metrics with clinical MS subtypes and lesion characteristics.
- To compare the efficacy of DBSI metrics against traditional measures like lesion volume.
Main Methods:
- Utilized DBSI to analyze brain white matter lesions and normal-appearing corpus callosum in 55 individuals with MS.
- Employed clinical MS subtypes as surrogates for underlying neuropathologies.
- Assessed metrics including restricted isotropic fraction, fiber fraction, radial diffusivity, and nonrestricted isotropic fraction.
Main Results:
- Restricted isotropic fraction and fiber fraction were key DBSI metrics for classifying MS using white matter lesions, outperforming lesion volume.
- In normal-appearing corpus callosum, fiber fraction, radial diffusivity, and nonrestricted isotropic fraction were significant predictors.
- DBSI metrics provided insights into cellularity, axonal density, myelination, and edema.
Conclusions:
- DBSI demonstrates potential as a noninvasive biomarker for assessing MS neuropathology.
- Specific DBSI metrics can differentiate MS subtypes and reflect distinct pathological processes.
- Further research is warranted to validate DBSI's role in clinical MS management.
